Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation PR Newswire
This study aims to evaluate the therapeutic application of N-acetylcysteine (NAC) as a treatment or adjunct therapy for various medical conditions. While its efficacy in treating acetaminophen overdose, cystic fibrosis, …
Study paves way for therapy, easier diagnosis in endometriosis BioWorld Online
Background/Objectives: Surgical removal of deep endometriosis lesions is an established method of reducing patient symptoms, but it often results in iatrogenic adhesions that lead to further problems. This pilot study …
Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study Nature.com
Endometriosis is a common disease, affecting approximately 5-10% of reproductively aged women. Symptoms, such as painful periods, negatively impact an individual's quality of life; however, these symptoms are often normalized, …
We describe a patient who presented with a symptomatic abdominal wall endometrioma. Therapy for such cases currently relies heavily on a surgical approach through laparoscopic means. This case demonstrates how …
Undifferentiated Endometrial Carcinoma Occurred During Perimenopausal Hormone Therapy: A Case Report and Literature Review Frontiers
A potential non-invasive stool test and novel therapy for endometriosis Medical Dialogues